Systemic vasculitides are heterogeneous disabling diseases characterised by chronic inflammation of the blood vessels potentially leading to tissue destruction and organ failure. The recent COVID-19 pandemic has had a significant impact on the epidemiology and management of patients with systemic vasculitis. In parallel, new insights have been provided on systemic vasculitis pathogenetic mechanisms, possible new therapeutic targets, and newer glucocorticoid-sparing treatments with better safety profiles. As in the previous annual reviews of this series, in this review we will provide a critical digest of the most recent literature regarding pathophysiology, clinical manifestations, diagnostic tools and treatment options in small- and large-vessel vasculitis focusing on precision medicine in vasculitis.

Moretti, M., Treppo, E., Monti, S., La Rocca, G., Del Frate, G., Delvino, P., et al. (2023). Systemic vasculitis: one year in review 2023. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 41(4), 765-773 [10.55563/clinexprheumatol/zf4daj].

Systemic vasculitis: one year in review 2023

Paolo Delvino;
2023

Abstract

Systemic vasculitides are heterogeneous disabling diseases characterised by chronic inflammation of the blood vessels potentially leading to tissue destruction and organ failure. The recent COVID-19 pandemic has had a significant impact on the epidemiology and management of patients with systemic vasculitis. In parallel, new insights have been provided on systemic vasculitis pathogenetic mechanisms, possible new therapeutic targets, and newer glucocorticoid-sparing treatments with better safety profiles. As in the previous annual reviews of this series, in this review we will provide a critical digest of the most recent literature regarding pathophysiology, clinical manifestations, diagnostic tools and treatment options in small- and large-vessel vasculitis focusing on precision medicine in vasculitis.
Articolo in rivista - Review Essay
antineutrophil cytoplasmic antibody associated vasculitis; cryoglobulinaemic vasculitis; eosinophilic granulomatosis with polyangiitis; giant cell arteritis; granulomatosis with polyangiitis; microscopic polyangiitis; systemic vasculitis; Takayasu's arteritis;
English
18-apr-2023
2023
41
4
765
773
reserved
Moretti, M., Treppo, E., Monti, S., La Rocca, G., Del Frate, G., Delvino, P., et al. (2023). Systemic vasculitis: one year in review 2023. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 41(4), 765-773 [10.55563/clinexprheumatol/zf4daj].
File in questo prodotto:
File Dimensione Formato  
Moretti-2023-Clin Exp Rheumatol-VoR.pdf

Solo gestori archivio

Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Licenza: Tutti i diritti riservati
Dimensione 412.56 kB
Formato Adobe PDF
412.56 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/467445
Citazioni
  • Scopus 15
  • ???jsp.display-item.citation.isi??? 3
Social impact